<DOC>
	<DOCNO>NCT02242292</DOCNO>
	<brief_summary>Study determine whether hyoscine butylbromide provide adequate symptomatic relief single episode - define lasting long 1 day - multiple episodes abdominal pain discomfort associate cramp use need</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Oral Doses Hyoscine Butylbromide Treatment Occasional Abdominal Pain , Cramping , Discomfort</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>1 . Adult male females 18 year age old 2 . Have least 3month selfreported history recurrent episodic symptom , usually last 1 hour , selfdescribed abdominal pain discomfort associate cramping , routinely either treat treat use Overthecounter ( OTC ) medication , subject suffer symptoms frequency least twice monthly several time weekly , daily basis . The episodes abdominal pain discomfort may associate symptom GI dysfunction , diarrhea , constipation , bloat 3 . Symptoms typically moderate great severity ( moderate , severe , severe ) sufficiently bothersome require treatment intervention 4 . Symptoms associate abdominal tenderness , swell , fever , weight loss , passage blood per rectum . The onset symptom may may associate ingestion food beverage 5 . The episodes abdominal pain discomfort may associate symptom GI dysfunction , diarrhea , cramp , constipation , bloat 6 . Subjects require able comprehend participate activity require participation trial , ability attend require site visit , available facility participate daily telephone call computer entry ( use touchtone phone computer IVRS entry ) , serve mechanism diary entry , 6week course study . Subjects require successfully complete Interactive voice response system ( IVRS ) training session prior entry study 7 . All subject complete sign informed consent form 1 . Subjects report symptom first time , particularly 50 year old , may sign serious organic disease 2 . Subjects know hypersensitivity allergy hyoscine butylbromide inactive ingredient 3 . Subjects currently physician 's care abdominal symptom and/or use medication use prescription OTC medication prescribe physician treat symptom abdominal pain , cramp discomfort take prescription medication ( ) treatment Irritable bowel syndrome ( IBS ) ( Bentyl® antispasmodic , Zelnorm® [ tegaserod ] , Lotronex® [ alosetron ] , prokinetic agent ) . Current physician 's care define subject presently follow clinician advice regard treatment management abdominal pain discomfort associate cramp symptom 4 . Subjects symptoms abdominal swelling , fever associate symptom abdominal pain discomfort associate cramping , and/or experience passage blood per rectum associate symptom abdominal pain discomfort associate cramping , evidence abdominal tenderness ( evidence acute abdomen ) , abdominal mass , organomegaly abnormality abdominal examination 5 . Subjects history colon GI cancer malignancy , inflammatory bowel disease , Crohn 's disease 6 . Subjects chronic constipation 7 . Subjects myasthenia gravis megacolon 8 . Subjects undergone abdominal surgery within past 2 year , GI surgery result removal part colon , small intestine , stomach , history GI bypass surgery weight reduction 9 . Prior history gallbladder removal , appendectomy , and/or surgery peptic ulcer disease gastroesophageal reflux disease ( GERD ) , exclusionary . 10 . Subjects whose major symptom retrosternal burning , acid reflux , acid regurgitation , heartburn exclude 11 . Subjects use prescription anticholinergic medication medication treatment myasthenia gravis , glaucoma , ocular hypertension exclude 12 . Subjects currently participate trial participate clinical trial within prior 30 day exclude 13 . Women report pregnant , nursing , childbearing potential use adequate method birth control ( medication , device , abstinence , sterilization either partner ) 30 day enrollment agree continue use adequate method birth control 30 day completion trial exclude 14 . Any woman childbearing potential positive serum pregnancy test exclude 15 . Postmenopausal woman postmenopausal duration le 2 year hysterectomy tubal ligation procedure exclude 16 . Subjects tachyarrhythmia ( define disturbance heart 's rhythm , regular irregular , result rate 100 beat per minute ) physical examination exclude 17 . Subjects previously diagnose benign prostatic hyperplasia ( BPH ) subject experienced urinary retention exclude 18 . Subjects clinically significant cardiovascular disease opinion investigator ( include hypotension , hypertension , severe coronary artery disease , congestive heart failure , angina pectoris ) exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>